ICD-10-CM Billable Code

M11.272

Other chondrocalcinosis, left ankle and foot

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code M11.272 refers to a medical condition known as other chondrocalcinosis affecting the left ankle and foot. Chondrocalcinosis, also called calcium pyrophosphate deposition disease (CPPD), involves the accumulation of calcium pyrophosphate crystals in the cartilage of joints. This condition can lead to joint pain, swelling, and decreased mobility. When localized to the left ankle and foot, it specifically impacts these areas, potentially causing discomfort and functional issues.

Causes & Symptoms

Clinical Causes: Aging process, which can increase the likelihood of crystal deposits in joints Genetic predisposition affecting cartilage and crystal formation Joint injuries or trauma that may trigger crystal accumulation Metabolic disorders such as hyperparathyroidism, hemochromatosis, or hypomagnesemia Other underlying joint diseases or degenerative conditions Previous joint infections or inflammation

Key Symptoms: Joint pain, especially during movement or pressure Swelling and inflammation around the affected ankle and foot Stiffness in the affected joints, reducing flexibility Tenderness to touch over the joint areas Possible redness or warmth in the affected regions Decreased range of motion, leading to difficulty walking or standing

Diagnostic & Treatment

Diagnosis Path: Diagnosing other chondrocalcinosis involving the left ankle and foot typically involves several steps: - **Medical history and physical examination:** The healthcare provider assesses symptoms and examines joint swelling or tenderness. - **Imaging studies:** X-rays are commonly used to identify calcification deposits in the cartilage; other imaging techniques like ultrasound or CT scans may provide additional detail. - **Joint fluid analysis:** A sample of joint fluid may be examined under a microscope to detect calcium pyrophosphate crystals. - **Laboratory tests:** Blood tests can help identify metabolic or systemic conditions that might contribute to crystal deposition. Accurate diagnosis is important to differentiate other forms of joint diseases and to develop appropriate treatment strategies.

Treatment Protocols: While there is no cure for chondrocalcinosis, management focuses on relieving symptoms and preventing joint damage: - **Medications:** Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to reduce pain and inflammation. Colchicine may be prescribed for flare prevention. - **Physical therapy:** Exercises and physical therapy can help improve joint strength and mobility. - **Joint protection:** Using supportive devices or braces can minimize joint stress. - **Lifestyle modifications:** Maintaining a healthy weight and managing comorbidities such as metabolic disorders can reduce the risk of crystal buildup. - **Invasive procedures:** In severe cases, joint aspirations or surgical interventions might be considered to remove excess crystals or repair damaged cartilage. Regular monitoring and a comprehensive approach are essential for managing chondrocalcinosis effectively.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M11.272 a billable ICD-10 code?
Yes, M11.272 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M11.272?
Clinical documentation must specify the nature of Other chondrocalcinosis, left ankle and foot and any associated comorbidities for accurate reporting.

Cite this Clinical Reference